Warren Eric - Insider Non-Derivative Transactions at Esperion Therapeutics, Inc. (ESPR) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 17, 2024, Warren Eric's relationship to Esperion Therapeutics, Inc. (ESPR) is Officer (Chief Commercial Officer), and currently has 162,659 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ESPR insiders.

Data Source: SEC.
Warren Eric - Insider Non-Derivative Transactions of ESPR Common Stock
Warren Eric - Insider Non-Derivative Transactions at ESPR
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 18, 2024 Sell -- (Common Stock) 2608 1.78 162659
Aug 20, 2024 Sell -- (Common Stock) 211 1.95 165267
Jul 18, 2024 Sell -- (Common Stock) 108 2.59 165478
Jun 19, 2024 Sell -- (Common Stock) 2540 2.86 165586
May 18, 2024 Sell -- (Common Stock) 192 2.48 168126
Mar 15, 2024 Acquisition -- (Common Stock) 100000 0 168318
Sep 21, 2023 Sell -- (Common Stock) 742 1.25 68318
Aug 19, 2023 Sell -- (Common Stock) 243 1.41 69060
Jul 20, 2023 Sell -- (Common Stock) 106 1.59 69303
Jun 22, 2023 Sell -- (Common Stock) 603 1.48 69409
May 18, 2023 Sell -- (Common Stock) 219 1.62 70012
Apr 20, 2023 Sell -- (Common Stock) 115 1.28 70231
Mar 18, 2023 Sell -- (Common Stock) 526 1.78 70346
Mar 15, 2023 Acquisition -- (Common Stock) 22300 0 70872
Mar 8, 2023 Sell -- (Common Stock) 5090 5.06 48572